Simcere Zaiming Collaborates With TargetRx To Intr...
Category : Licensing/Collaboration Deal 4 September 2024Overview Simcere Zaiming, an innovative oncology company under Simcere Pharmaceutical Group, anno...
Overview Simcere Zaiming, an innovative oncology company under Simcere Pharmaceutical Group, anno...
Alkem Labs signs a non-exclusive patent license agreement with Takeda to commercialise vonoprazan in...
Seegene partners with Springer Nature to launch ‘Nature Awards MDx Impact Grants’ to inn...
Overview Jacobio Pharma has announced the transfer of rights for its KRAS G12C inhibitor, glecira...
CancerVax enters agreement with Flashpoint Therapeutics for research on Universal Cancer Treatment p...